Tepezza 75987-0130
Generic: Teprotumumab
Product NDC
75987-0130- Manufacturer
- Horizon Therapeutics Usa, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 21, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761143
Need to source Tepezza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Teprotumumab | 500 mg/1 |
Drug Class
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE